Artesunate Inhibits the Development of Esophageal Cancer by Targeting HK1 to Reduce Glycolysis Levels in Areas With Zinc Deficiency.

Front Oncol · 2022 · PMC9133444 · PMID 35646662

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

There was a clear trend of separation between the cells treated with artesunate and the controls ( Figure 2A ), and all the QC samples showed good aggregation, which means there was good quality control ( Figure 2B ).

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.